Know Labs, a leader in breakthrough technology for medical grade diagnostics and disease prevention, was seeking to build visibility, credibility and differentiation among investors and health care professionals for its non-invasive diagnostic technology. The company turned to Linhart PR for strategic counsel, content development and earned media in support of the company’s business goals, including progress toward commercialization of the company’s proprietary non-invasive medical-grade diagnostic technology.
Linhart PR was responsible for laying the groundwork with media to position the company as a credible key player in non-invasive diagnostics. The start-up hadn't yet delivered a working prototype and was still working toward the FDA submission process, which limited interest from mainstream national media contacts.
Linhart PR led a successful earned media outreach campaign from mid-2021 through mid-2023, elevating the company’s approach to sharing company announcements through message improvements and by proposing creative, proactive pitch ideas for and in between announcements to create momentum and make news.
Additionally, Linhart PR recommended the company pursue a membership with Forbes Tech Council to share expertise via paid thought leadership content on Forbes.com. Linhart PR secured a membership for the chairman and CEO, helping position him and Know Labs as thought leaders in the med tech industry and on non-invasive diagnostics. Linhart PR developed the five articles.
Over a two-year period, Linhart PR secured 115+ news articles resulting in more than 26 million qualified impressions. Coverage reached an audience of investors and health and med tech companies, as well as the diabetes management community, through media outlets including MarketWatch, Fierce Biotech, Medical Device and Diagnostic Industry, Drug Delivery Business, BioWorld, Healthline Diabetes Mine and MedTech Insight.
Additionally, Know Labs submitted five articles to the Forbes Tech Council, for a total viewership of more than 2,000 qualified readers.